Advanced Acne Spot Treatment

Manufacturer
Shanghai Weierya Daily Chemicals Factory
Effective date
2016-01-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:44:36

Label at a glance#

ProductAdvanced Acne Spot Treatment
Active ingredientSALICYLIC ACID
Label structure9 sections

Storage and handling

Other information store at room temperature 68 - 86 F (20 - 30 C)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient

Salicylic acid  2%

OTC - PURPOSE SECTION

Purpose

Acne treatment

INDICATIONS & USAGE SECTION

Uses  for the treatment of acne

WARNINGS SECTION

Warnings

For external use only.

Flammable. Keep away from fire or flame.

Ask a doctor or pharmacist before using other topical

acne medications at the same time or immediately

following use of this product. May increase dryness or

irritation of the skin. If this occurs, only one medication

should be used unless directed by a doctor.

When using this product apply to affected area only.

Do not use on broken skin or apply to large areas of the

body.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get

medical help or contact a Poison Control Center right

away.

DOSAGE & ADMINISTRATION SECTION

Directions

-Cleanse skin thoroughly before applying.

-Cover the entire affected area with a thin layer one to

three times daily. Because excessive drying of the skin

may occur, start with one application daily, then

gradually increase to two or three times daily if needed

or directed by a doctor. If bothersome dryness or

peeling occurs, reduce application to once a day or

every other day.

STORAGE AND HANDLING SECTION

Other information store at room

temperature 68 - 86 F (20 - 30 C)

INACTIVE INGREDIENT SECTION

Inactive ingredients  alcohol, ammonia,

benzalkonium chloride, butylene glycol, dimethicone,

disodium EDTA, glycerin, hamamelis virginiana extract,

laureth-7, menthyl lactate, paraffin, phenoxyethanol,

polyacrylamide, portaluca oleracea extract, propylene

glycol, water, xanthan gum

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

copy of labelcopy of label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN1
346298salicylic acid 0.02 MG/MG Topical GelSCD1
346298salicylic acid 2 % Topical GelSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58194-030-012020-01-31C16284748780-19d75b9d0-ac93-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58194-030-01Advanced Acne Spot Treatment1 in 1 CARTONGEL11
58194-030-01Advanced Acne Spot Treatment21 g in 1 TUBEGEL211

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58194-030ADVANCED ACNE SPOT TREATMENT (SALICYLIC ACID) GEL [SHANGHAI WEIERYA DAILY CHEMICALS FACTORY]1Legacy NDC, 2 package rows20160113_ee4224cb-6e17-496d-8dc9-47dcfc3c5c4a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58194-03058194-030-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
83981039-7f29-40e3-83fa-4496ae3c7e03ee4224cb-6e17-496d-8dc9-47dcfc3c5c4a2016-01-10WarningsExact identifier
spl id: 83981039-7f29-40e3-83fa-4496ae3c7e03
spl set id: ee4224cb-6e17-496d-8dc9-47dcfc3c5c4a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.